Moleculin Biotech, Inc.
MBRXNASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $2.10M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.16$15.75
- Volume (live)
- -
- Avg. volume (3M)
- 988.81K
Moleculin Biotech (MBRX) Stock Price & Financial Analysis
Moleculin Biotech Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.28 - $0.33 |
|---|---|
| 52-Week High | $15.75 |
| 52-Week Low | $0.16 |
| Open | $0.31 |
| Volume (last close) | 1.17M |
| Average Volume (3M) | 988.81K |
| 50-Day MA | $0.58 |
|---|---|
| 200-Day MA | $2.23 |
| 1-Year Change | −97.10% |
| Market Cap | 2.10M |
|---|---|
| Shares Outstanding | 5.68M |
| Price to Book (P/B) | 0.18 |
| EV/EBITDA | 0.19 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Moleculin Biotech at a Glance
As of the Oct 16, 2026 close, Moleculin Biotech (MBRX) has a market capitalization of $2.10M.
As of its latest reported balance sheet, it holds $7.26M in cash and securities against $292.00K of debt, a net cash position of $6.97M.
Moleculin Biotech does not currently pay a dividend.
The share price is down 97.1% over the past year. At $0.28 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.16 to $15.75, below its 200-day moving average of $2.23.
Frequently Asked Questions About Moleculin Biotech
What is the current stock price for MBRX?
As of the Oct 16, 2026 close, MBRX stock trades at $0.28. The 52-week range is $0.16–$15.75, with a day range of $0.28–$0.33.
What is the P/E ratio for MBRX?
The P/E ratio (Price-to-Earnings) for MBRX is shown in the Key Statistics section. This valuation metric helps compare Moleculin Biotech, Inc. to industry peers.
Does MBRX pay dividends?
Moleculin Biotech does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MBRX?
Analyst ratings and recommendations for MBRX are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of MBRX?
As of the Oct 16, 2026 close, Moleculin Biotech's market capitalization is $1.6M, classifying it as a micro-cap company. Moleculin Biotech operates in the Healthcare sector within the Biotechnology industry.